인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
DBpia AI
AI 에이전트
AI 아이디어
AI 리더
AI 뷰어
Citeasy
크롬 서지관리 다운로드
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
Research on Electronic Bidding Evaluation System for Chinese drug Procurement
논문 기본 정보
- 저자정보
- 저널정보
- 인하대학교 정석물류통상연구원 인하대학교 정석물류통상연구원 학술대회 Proceedings of the 3rd International conference on risk management &Global e-business(volume 2)
- 발행연도
- 2009.10
- 수록면
- 768 - 772 (5page)
피인용 0
Research on Electronic Bidding Evaluation System for Chinese drug Procurement
초록·키워드
Since the reform and opening-up, China has shifted its planed economy to a socialist market economy. It gives a boost to the pharmaceutical enterprises and consequent the force competition. However, differs from some European countries, Chinese drug dispensing doesn’t separate from medical practice. All those lead to serious commercial bribes and high drugs price which the people cannot afford. China has constantly explored the Public Bidding of drug procurement since 2001. The third-party bidding agency integrated the computer science with Chinese-specialized drug bidding and then developed into an Electronic Bidding System. Unfortunately, the system seems to be unavailable to cut the drug price down. There still existed serious commercial bribes during the purchasing. Bidding evaluation is the core step in E-Bidding System, which has a direct impact in the bidding result. This article makes a concrete analysis of the Bidding Evaluation System and points out the main problems, So the author will give us some feasible suggestions to improve the E-Bidding System, such as expanding the expert database; improving the searching method; selecting the experts randomly and automatically; notifying the experts by technological means instead of manual work and establishing blacklist for the experts. Therefore, China’s E-Bidding System will have a better future.
본문·목차
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
최근 본 자료 전체보기
UCI(KEPA) : I410-ECN-0101-2013-000-001295733
